|
|
|
| |
 |
|
|
|
推薦指數：
|
|
- 內容介紹
|
Evidence-Based Cardiology, 3rd Edition
Salim Yusuf (Editor), John Cairns (Editor), John Camm (Editor), Ernest L. Fallen (Editor), Bernard J. Gersh (Editor)
ISBN: 978-1-4051-5925-8
Hardcover
1240 pages
Pub Date:2010, BMJ Books
Evidence based Cardiology was first published in 1998 to universal acclaim. Now, with the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence-based practice is a more important force in health care delivery than ever.
This new third edition, written by the world’s leading cardiologists, provides graded evidence-based reviews of the major trials together with recommendations for optimum management, and now includes new grading and recommendation methodology.
This is a unique book in the field of cardiology, and the largest evidence based clinical cardiology text
Part I: General concepts and critical appraisal.
1 What is evidence-based cardiology? - PJ Devereaux.
2 A critical appraisal of the cardiovascular history and physical examination - Ernest Fallen.
3 Obtaining incremental information from diagnostic tests - Raymond J Gibbons.
4 Clinical trials and meta-analysis - Colin Baigent, Jonathan Emberson, S Yusuf.
5 Understanding concepts related to health economics - Mark Hlatky.
6 Perioperative Cardiovascular Risk - PJ Devereaux.
7 Implementing evidence based cardiology - Brahmajee Nallamothu, Thomas Tsai.
8 CV Disease and occupational health issues - Michael Joy.
PART II Prevention of cardiovascular diseases.
9 Global perspective on cardiovascular disease - K Srinath Reddy.
10 Tobacco: global burden and community solutions - Prabhat Jha.
11 Tobacco and cardiovascular disease: achieving smoking cessation in individuals - Andrew Pipe.
12 Lipids and cardiovascular disease - Malcolm Law.
13 Use of lipid lowering agents in the prevention of cardiovascular disease - Jeffrey L Probstfield, Alan Failor.
14 Blood pressure and cardiovascular disease - Curt Furberg, Bruce M. Psaty, Elsayed Soliman.
15 Glucose abnormalities and cardiovascular disease: "dysglycemia" as an emerging cardiovascular risk factor - Hertzel C Gerstein.
16 Physical activity and exercise in cardiovascular disease prevention and rehabilitation - Ray Squires.
17 Psychosocial factors - Annika Rosengren.
18 Social influences / Social Determinants of Heart Disease - Martin McKee, Clara Chow.
19 Emerging approaches in cardiovascular prevention - Eva M Lonn, Salim Yusuf.
20 Obesity - Arya M Sharma, Raj Padwal.
21 Ethnicity and cardiovascular disease - Sonia S Anand, Clara Chow.
22 The fetal origins of coronary heart disease - Stephanie Atkinson, Katherine Morrison, Koon Teo.
23 Molecular genetics of cardiovascular disorders – atherosclerosis, Bernard Keavney.
24 Molecular genetics of cardiomyopathies and other disorders - Robert Roberts, Ali Marian.
25 Diet and the Global Burden - Srinath Reddy.
26 Integrating approaches to prevention of cardiovascular disease - David Wood.
PART IIIa Stable coronary artery disease.
27 Medical management of stable coronary artery disease - William Boden.
28 Percutaneous Intervention - Dave Wood, Chris Buller, Bernard Gersh, Salim Yusuf.
29 Surgical Coronary Artery Revascularization - Thorald Sundt, Bernard Gersh, Salim Yusuf, Morgan Brown.
30 Comparisons of PCI and CABG - Arashk Motiei, Charanjit S. Rihal.
PART IIIb Acute Coronary Syndromes.
31 Unstable Angina and Non-ST-segment MI - Pierre Theroux, John Cairns.
32 Early Management of ST-segment-elevation MI - Paul Armstrong, Rob Welsh.
33 Reperfusion therapies for STEMI - J. Brent Muhlestein.
34 Antithrombotic therapies for patients with STEMI - Keith Fox, Andrew Lucking.
35 Complications of STEMI - Peter L Thompson.
36 An integrated approach to the management of patients after the early phase of STEMI - Pedro L Sánchez, Fernando Aviles.
PART IIIc Arrhythmias.
37 Atrial fibrillation: rate versus rhythm? - Albert Waldo.
38 Atrial fibrillation: Upstream therapies - Antonios Kourliouros, Irina Savelieva, Marjan Jahangiri, John Camm.
39 Atrial fibrillation: antithrombotic therapy - John A Cairns, Stuart Connolly.
40 Atrial fibrillation: ablation therapy - Andrea Natale, CK Ching.
41 Supraventricular tachycardia: drugs v ablation - Gerald Naccarelli, Erica D. Penny-Peterson.
42 Prevention and treatment of life-threatening ventricular arrhythmia and sudden death - Carlos Morillo.
43 Pacemaker Therapy, including Bi-ventricular Pacing - William Toff, John Camm.
44 Syncope - David Benditt, Fei Lu, Scott Sakaguchi.
45 Cardiopulmonary resuscitation - Michael Colquhoun.
46 New and Old antiarrhythmic Drugs - John Camm, Irina Savelieva.
47 Arrhythmias due to monogenic disorders - Dan Roden, P. Kannankeril, Dawood Darbar.
48 Arrhythmiagenic right ventricular cardiomyopathy (ARVC) - Deirdre Ward, Perry M Elliott.
PART IIId Specific cardiovascular disorders: Left ventricular dysfunction.
49 Epidemiology and prevention of congestive heart failure and treatment of asymptomatic left ventricular dysfunction - John McMurray, Paul Rocchiccioli.
50 Management of overt heart failure - Karl Swedberg, Karl Hauptman.
51 Acute myocarditis and dilated cardiomyopathy - Leslie Cooper, Oyere Onuma.
52 Management of Hypertrophic Cardiomyopathy - Barry Maron.
53 Infective and infiltrative cardiomyopathies - Perry Elliott.
54 Chagas’ disease - Jose A Marin-Neto, Anis Rassi Júnior, Benedito Carlos Maciel, Marcus Vinícius Simoes, André Schmidt.
PART IIIe Specific cardiovascular disorders: Pericardial disease.
55 Pericardial disease: an evidence-based approach to diagnosis and treatment - Faisal F Syed, Bongani M Mayosi.
PART IIIf Specific cardiovascular disorders: Valvular heart disease.
56 Rheumatic heart disease: prevention and acute treatment - Patrick J Commerford, Bongani Mayosi.
57 Mitral valve disease: indications for surgery - Blasé A Carabello.
58 Surgical Indications in Aortic valve Disease - Heidi M Connolly, Sunil Mankad, Shahbudin H Rahimtoola.
59 Nonsurgical aortic valve therapy. Balloon valvuloplasty and transcatheter aortic valve implantation - Robert H Boone, John Webb.
60 Balloon valvuloplasty: mitral valve - Zoltan G Turi.
61 Valve repair and choice of valves - Shafie S Fazel, Tirone E. David.
62 Diagnosis, management and prevention of infective endocarditis - Andrew Wang.
63 Antithrombotic therapy after heart valve replacement - John W. Eikelboom, Jack C.J. Sun.
PART IIIg Specific cardiovascular disorders: Other conditions.
64a Management of acute stroke - Ashfaq Shuaib, Brian Buck.
64b Secondary prevention of stroke - Craig Anderson.
65 Heart disease and pregnancy - Samuel C Siu, Rachel Wald.
66 Adult congenital heart disease - Elisabeth Bédard, Michael Gatzoulis.
67 Venous thromboembolic disease - Lori Linkins, Clive Kearon.
68 Peripheral vascular disease - Sonia Anand, Catherine McGorrian.
69 Cardiac risk in those undergoing non cardiac surgery - Kim Eagle, Ameeth Verde.
70 Clinical Management of Diseases of the Aorta - Thor Sundt.
71 Cardiac transplantation: indications and post operative management - Sudhir Kushwaha, Barry Boilson.
72 Renal dysfunction - Johannes Mann, Regina Kunz, Hertzel C. Gerstein, Ernesto L. Schiffrin.
73 Pulmonary hypertension - Brendan Madden.
PART IV Clinical applications.
74 Clinical applications of external evidence - Ernest L Fallen, Salim Yusuf.
75 Stable angina: choice of PCI v CABG v drugs - William Weintraub.
76 Acute coronary syndromes - David Fitchett, Ernest Fallen.
77 Acute ST segment elevation myocardial infarction (STEMI) - Ernest L Fallen.
78 Metabolic risk and Post myocardial infarction management - Jacques Genest Jr.
79 Heart failure - Michael M Givertz, Garrick Stewart.
80 Atrial fibrillation - Michael Klein.
81 Ventricular dysrhythmias: pharmacologic v non-pharmacologic treatment - Jeffrey S Healey.
82 Bradyarrhythmias: Management and choice of pacemakers - Carlos Morillo.
83 Peripheral vascular disease with suspect coronary artery disease - Victor Aboyans, Michael Criqui.
84 Valvular heart disease: timing of surgery - Victor Chu, Jon-David Schwalm
|
|
|
其他相關書藉
[ 
[ 